- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 265 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 179 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 208 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,900GBP
- Report
- April 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Book
- September 2023
- 288 Pages
- Book
- June 2021
- 592 Pages
- Book
- April 2020
- 336 Pages
- Book
- April 2019
- 816 Pages
- Book
- July 2018
- 832 Pages
- Book
- September 2016
- 680 Pages
- Book
- May 2016
- 288 Pages
- Book
- March 2015
- 352 Pages
- Book
- October 2013
- 624 Pages
- Book
- October 2012
- 456 Pages
- Book
- April 2012
- 1272 Pages
- Book
- September 2010
- 424 Pages
- Book
- May 2009
- 354 Pages

Liver failure is a condition in which the liver is unable to perform its normal functions. It is a major cause of death in the United States and is a major focus of hepatology, the branch of medicine that deals with the diagnosis and treatment of diseases of the liver. Liver failure can be caused by a variety of factors, including viral hepatitis, alcohol abuse, and certain medications. Symptoms of liver failure include jaundice, abdominal pain, fatigue, and confusion. Treatment of liver failure typically involves supportive care, such as intravenous fluids and nutrition, as well as medications to reduce symptoms. In some cases, a liver transplant may be necessary.
The liver failure market includes a variety of companies that develop and market products for the diagnosis and treatment of liver failure. These include pharmaceutical companies that develop medications to treat liver failure, medical device companies that develop devices to monitor liver function, and biotechnology companies that develop treatments for liver failure. Show Less Read more